We study how the host adaptive immune response coevolves with pathogens, especially in ways relevant to epidemiological and evolutionary forecasting, vaccine design, and pathogen diversity. Our work is computational, and we collaborate closely with immunologists and epidemiologists.
We argue in Nature Reviews Immunology that concerns about evolution should not hold back efforts to expand vaccination coverage, including through delayed second dosing. Sarah presented this case in an invited talk at the WHO Global Consultation on SARS-CoV-2 variants on March 29, and the paper was mentioned in Stat.
April 1, 2021
Katie and Sarah discuss epidemic metrics with Quanta Magazine, which had also interviewed Katie in January. We have also recently talked with the New York Times, Al Jazeera, Washington Post, Science, Nature, The Atlantic, Vox (twice), Stat, MIT Technology Review, Scientific American, ABC News, Science News, and BBC Future. Vaccine misallocation at U. Chicago was covered in the Chicago Tribune.
March 23, 2021
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination in Nature Reviews Immunology (2021)